788 related articles for article (PubMed ID: 20494358)
1. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
Faber DR; van der Graaf Y; Westerink J; Visseren FL
Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
[TBL] [Abstract][Full Text] [Related]
2. Increased visceral adipose tissue is associated with increased resting heart rate in patients with manifest vascular disease.
Bemelmans RH; van der Graaf Y; Nathoe HM; Wassink AM; Vernooij JW; Spiering W; Visseren FL;
Obesity (Silver Spring); 2012 Apr; 20(4):834-41. PubMed ID: 22016101
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity.
Lu B; Yang Y; Yang Z; Feng X; Wang X; Zhang Z; Hu R
Cardiovasc Diabetol; 2010 Dec; 9():92. PubMed ID: 21167068
[TBL] [Abstract][Full Text] [Related]
4. Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study.
de Mutsert R; Gast K; Widya R; de Koning E; Jazet I; Lamb H; le Cessie S; de Roos A; Smit J; Rosendaal F; den Heijer M
Metab Syndr Relat Disord; 2018 Feb; 16(1):54-63. PubMed ID: 29338526
[TBL] [Abstract][Full Text] [Related]
5. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.
Chou HH; Hsu LA; Liu CJ; Teng MS; Wu S; Ko YL
Metabolism; 2010 Jun; 59(6):824-30. PubMed ID: 20004425
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress is associated with C-reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance.
Park S; Kim M; Paik JK; Jang YJ; Lee SH; Lee JH
Clin Endocrinol (Oxf); 2013 Jul; 79(1):65-70. PubMed ID: 22816656
[TBL] [Abstract][Full Text] [Related]
8. Associations of Body Mass Index and Body Fat With Markers of Inflammation and Nutrition Among Patients Receiving Hemodialysis.
Delgado C; Chertow GM; Kaysen GA; Dalrymple LS; Kornak J; Grimes B; Johansen KL
Am J Kidney Dis; 2017 Dec; 70(6):817-825. PubMed ID: 28870376
[TBL] [Abstract][Full Text] [Related]
9. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy.
Carbone F; Nulli Migliola E; Bonaventura A; Vecchié A; De Vuono S; Ricci MA; Vaudo G; Boni M; Dallegri F; Montecucco F; Lupattelli G
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):494-500. PubMed ID: 29502925
[TBL] [Abstract][Full Text] [Related]
10. Protein-Bound Plasma Nε-(Carboxymethyl)lysine Is Inversely Associated With Central Obesity and Inflammation and Significantly Explain a Part of the Central Obesity-Related Increase in Inflammation: The Hoorn and CODAM Studies.
Gaens KH; Ferreira I; van de Waarenburg MP; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Rensen SS; Stehouwer CD; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2707-13. PubMed ID: 26449750
[TBL] [Abstract][Full Text] [Related]
11. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians.
Forouhi NG; Sattar N; McKeigue PM
Int J Obes Relat Metab Disord; 2001 Sep; 25(9):1327-31. PubMed ID: 11571595
[TBL] [Abstract][Full Text] [Related]
12. Serum CETP concentration is not associated with measures of body fat: The NEO study.
Blauw LL; de Mutsert R; Lamb HJ; de Roos A; Rosendaal FR; Jukema JW; Wang Y; van Dijk KW; Rensen PC
Atherosclerosis; 2016 Mar; 246():267-73. PubMed ID: 26820801
[TBL] [Abstract][Full Text] [Related]
13. The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis.
Christen T; Trompet S; Rensen PCN; Willems van Dijk K; Lamb HJ; Jukema JW; Rosendaal FR; le Cessie S; de Mutsert R
Nutr Metab Cardiovasc Dis; 2019 Jul; 29(7):728-735. PubMed ID: 31138500
[TBL] [Abstract][Full Text] [Related]
14. The role of C-reactive protein, adiponectin and leptin in the association between abdominal adiposity and insulin resistance in middle-aged individuals.
Noordam R; Boersma V; Verkouter I; le Cessie S; Christen T; Lamb HJ; Rosendaal FR; Willems van Dijk K; van Heemst D; de Mutsert R
Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1306-1314. PubMed ID: 32507340
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and incident diabetes in patients with arterial disease.
Verhagen SN; Wassink AM; van der Graaf Y; Visseren FL;
Eur J Clin Invest; 2013 Oct; 43(10):1052-9. PubMed ID: 23919838
[TBL] [Abstract][Full Text] [Related]
16. The relation of body fat mass and distribution to markers of chronic inflammation.
Festa A; D'Agostino R; Williams K; Karter AJ; Mayer-Davis EJ; Tracy RP; Haffner SM
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1407-15. PubMed ID: 11673759
[TBL] [Abstract][Full Text] [Related]
17. Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study.
Philipsen A; Jørgensen ME; Vistisen D; Sandbaek A; Almdal TP; Christiansen JS; Lauritzen T; Witte DR
PLoS One; 2015; 10(4):e0123062. PubMed ID: 25849815
[TBL] [Abstract][Full Text] [Related]
18. Influence of visceral obesity and liver fat on vascular structure and function in obese subjects.
Sturm W; Sandhofer A; Engl J; Laimer M; Molnar C; Kaser S; Weiss H; Tilg H; Ebenbichler CF; Patsch JR
Obesity (Silver Spring); 2009 Sep; 17(9):1783-8. PubMed ID: 19325543
[TBL] [Abstract][Full Text] [Related]
19. High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes.
Bouchi R; Takeuchi T; Akihisa M; Ohara N; Nakano Y; Nishitani R; Murakami M; Fukuda T; Fujita M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2015 Oct; 14():136. PubMed ID: 26445876
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
